4Roth C, Leonhardt S, Seidel C, et al. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model [ J ]. Pediatr Res, 2000, 48 (4) : 468 - 474.
5Roth C, Hege mann FI Hildrandt J, et al. Ituitary and gonadal effects of GnRH (gonadotropirr releasing hormone) analogues in two peripubertal female rat models [J] . Pediatr Res, 2004, 55 ( 1 ) : 126 - 133.
6Wu MH, Lin SJ, cheng YC, et al. Clinical suppression of Precocious Puberty with cetrorelix after failed treat ment with GnRH agonist in a girl with gonad otrophin-independent precocious puberty[J]. Reprod Biomed Online, 2005, 11(1): 18 -21.
8Heger S, Partsch C J, Sippell WG, et al. Long-term outcome after depot gonadotropin-release hormone agonist treatment of central precocious puberty: final height, proportions, body composition,bone/mineral density, and reproductive function. J Clin Endocrinal Meta, 1999, 84:4583 - 4590.
9Sluis IM, Boot AM, Krenning EP, et al. Longitudinal follow-up of bone density and bone composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. J Clin Endocrinal Meta, 2003, 87:506 - 512.
10Klein KO. 1999 Precocious Puberty. Who has it? Who should be treated? J Clin Endocrinal Meta, 1999, 84:411 - 414.
